You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 25, 2024

List of Excipients in API lapatinib

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing lapatinib

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	TYKERB	lapatinib	0078-0671	CELLULOSE, MICROCRYSTALLINE
Novartis Pharmaceuticals Corporation	TYKERB	lapatinib	0078-0671	FD&C YELLOW NO. 6
Novartis Pharmaceuticals Corporation	TYKERB	lapatinib	0078-0671	HYPROMELLOSES
Novartis Pharmaceuticals Corporation	TYKERB	lapatinib	0078-0671	MAGNESIUM STEARATE
Novartis Pharmaceuticals Corporation	TYKERB	lapatinib	0078-0671	POLYETHYLENE GLYCOL
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing lapatinib

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC	Excipient
Lupin Pharmaceuticals Inc	lapatinib	68180-801	FD&C YELLOW NO. 6
Lupin Pharmaceuticals Inc	lapatinib	68180-801	HYPROMELLOSE
Lupin Pharmaceuticals Inc	lapatinib	68180-801	LECITHIN, SOYBEAN
Lupin Pharmaceuticals Inc	lapatinib	68180-801	MAGNESIUM STEARATE
Lupin Pharmaceuticals Inc	lapatinib	68180-801	MICROCRYSTALLINE CELLULOSE 101
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for lapatinib

Excipient focus: CELLULOSE, MICROCRYSTALLINE

lapatinib drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

lapatinib drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

Excipient focus: FD&C YELLOW NO. 6

lapatinib drug variants containing FD&C YELLOW NO. 6

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing FD&C YELLOW NO. 6

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSE

lapatinib drug variants containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing HYPROMELLOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

lapatinib drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

lapatinib drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

Excipient focus: LECITHIN, SOYBEAN

lapatinib drug variants containing LECITHIN, SOYBEAN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing LECITHIN, SOYBEAN

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

lapatinib drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

lapatinib drug variants containing MICROCRYSTALLINE CELLULOSE 101

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing MICROCRYSTALLINE CELLULOSE 101

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL

lapatinib drug variants containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

lapatinib drug variants not containing POLYETHYLENE GLYCOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 400

lapatinib drug variants containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Excipient focus: POLYSORBATE 80

lapatinib drug variants containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing POLYSORBATE 80

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

lapatinib drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE

lapatinib drug variants containing POVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

lapatinib drug variants not containing POVIDONE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE K30

lapatinib drug variants containing POVIDONE K30

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing POVIDONE K30

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

lapatinib drug variants containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing SODIUM STARCH GLYCOLATE TYPE A

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

lapatinib drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

lapatinib drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

Excipient focus: TALC

lapatinib drug variants containing TALC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing TALC

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

lapatinib drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: XANTHAN GUM

lapatinib drug variants containing XANTHAN GUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Lupin Pharmaceuticals Inc	lapatinib	68180-801
>Company	>Ingredient	>NDC

lapatinib drug variants not containing XANTHAN GUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	lapatinib	0078-0671
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.